✦ LIBER ✦

Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series

✍ Scribed by K.K. Shih; D.S. Chi; R.R. Barakat; M.M. Leitao Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beyond tertiary cytoreduction in patient

✍ K.K. Shih; D.S. Chi; R.R. Barakat; M.M. Leitao Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Phase II evaluation of topotecan and nav

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall K. Gibb; Lynne Lipp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Bevacizumab Combination Therapy: A Revie

✍ Dhillon, Sohita 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 503 KB

Phase 1–2 study of docetaxel plus aflibe

✍ Robert L Coleman; Linda R Duska; Pedro T Ramirez; John V Heymach; Aparna A Kamat 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 208 KB

A phase II trial of weekly docetaxel in

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Celiac lymph node resection and porta he

✍ A. Martinez; C. Pomel; E. Mery; D. Querleu; L. Gladieff; G. Ferron 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 811 KB